Bipolar disorder and borderline personality disorder share symptoms but are distinct. Learn how to tell them apart and why ...

BPD is characterized by extreme emotional dysregulation, whereas schizophrenia mainly involves a disconnect from reality ...

Cognitive behavioral therapy (CBT) can help you identify and replace negative or damaging behaviors learned in your past. It can be helpful to people with various mental health conditions.

The book contains 10 chapters that cover everything about BPD, from an explanation of what exactly the disorder is to the types of therapy and medications that are useful to treat the disorder.

Occupational therapy can address physical, social, educational, and organizational deficits with a plan focused on your individual skills, needs, and activities. Read on to learn more about how an ...

Minister Bahlil Lahadalia said late on Monday, after a meeting with President Prabowo Subianto, that the planned capacity for the new refineries would be doubled to 1 million bpd. He said ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...

In this way, the aims of therapy would be to assess which “normal” activities we aspire to that are mere distractions or self-cures for deeper wants or desires or our general ambivalence with the ...

Psychologists share ways to dig yourself out of a therapy rut. By Christina Caron Therapy has been a part of Katerina Kelly’s weekly routine since elementary school, when a teacher suggested ...

This is a phase where the signs and symptoms of the condition are either gone or very low, but the person still has BPD. Symptoms may return after remission, but they are usually milder. Psychotherapy ...

Borderline Personality Disorder (BPD) is one of the most misunderstood mental health conditions. If you’ve heard anything about it before, it was likely framed in extremes—overwhelming ...

Despite their immense potential, gene and cell therapies that target rare diseases are at risk of market withdrawal, owing to several challenges. The authors describe these hurdles and call for ...